Ayperi Öztürk, Funda Demirağ, Ebru Tatcı, Özlem Özmen
Molecular Imaging and Radionuclide Therapy
101-106
Pharmacokinetic Modeling of 18F-FDOPA PET in the Human Brain for Early Parkinson’s Disease
Molecular Imaging and Radionuclide Therapy
Wirunpatch BURATACHWATANASİRİ, Maythinee CHANTADİSA, Jaruwan ONWANNA, Yuda CHONGPİSON, Yothin RAKVONGTHAİ, Kitiwat KHAMWAN
Molecular Imaging and Radionuclide Therapy
Mehmet ERDOGAN, Hakan KORKMAZ, Bora TORUS, Mustafa AVCI, Şerife Mehtap BOYLUBAY, İbrahim Metin CİRİŞ, Mustafa YILDIZ, Sevim Süreyya SENGUL
Molecular Imaging and Radionuclide Therapy
Zümrüt ARDA KAYMAK, Nermin KARAHAN, Mehmet ERDOGAN, Evrim ERDEMOĞLU, İsmail ZİHNİ, Şengül BİLGİN
Molecular Imaging and Radionuclide Therapy
Ebru TATCI, Özlem ÖZMEN, Ayperi ÖZTÜRK, Funda DEMİRAĞ
Molecular Imaging and Radionuclide Therapy
Nada ALMENİEİR, Marc HİCKESON, Javier NOVALES-DİAZ, Vilma DERBEKYAN, Gad ABİKHZER
PET/CT Findings of a Patient with Striped Muscle Metastasis of Invasive Breast Carcinoma
Molecular Imaging and Radionuclide Therapy
Rabiye USLU ERDEMİR, Özlem ELMAS
68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
Molecular Imaging and Radionuclide Therapy
Cihan GÜNDOĞAN, Nurhan ERGÜL, Mehmet Semih ÇAKIR, Özgür KILIÇKESMEZ, Rıza Umar GÜRSU, Tamer AKSOY, Tevfik Fikret ÇERMİK
Oncological Follow-up with 2-[18F]-FDG PET/CT in Li-Fraumeni Syndrome
Molecular Imaging and Radionuclide Therapy
Marylin Acu a HERNANDEZ, https orcid.org - - -, Lina L pez V LEZ, Catalina Melo ARANGO